Menu
Menu
A peptide for tendons, joints, gut comfort, and the structural foundation underneath.
Not FDA-approved · Investigational use
BPC-157 is a 15-amino-acid peptide, a fragment of a larger protein originally identified in human gastric juice. The name (Body Protection Compound) reflects its proposed role in tissue defense and repair.
The animal literature on BPC-157 is substantial. Rodent studies have documented accelerated tendon and ligament healing, gastrointestinal mucosal protection, and effects on angiogenic and growth-factor pathways. The proposed mechanisms involve VEGFR2 signaling, nitric oxide modulation, and growth-hormone-receptor effects on tendon cells.
Human clinical evidence is much thinner. A registered Phase 1 safety trial in healthy adults was launched in 2015 but never published results. A small published intravenous safety pilot exists. There is no completed published human efficacy trial. We discuss this evidence picture honestly with every patient who asks about BPC-157.
Response is individual; we don’t guarantee outcomes.
We injection near the area of concern when it’s reasonable to do so. The animal work suggests local exposure matters for tendon, ligament, and gut tissue, and clinical practice has followed that pattern.
Cycle length is matched to what’s being addressed. A recent strain might run 4 weeks. A long-standing tendinopathy or persistent gut issue might run 8 weeks, with a break before deciding whether to repeat.
Two things are worth knowing before starting. BPC-157 has no completed published human efficacy trial. And it is on the prohibited substance list for tested athletes (USADA, WADA-monitored). We don’t recommend it for anyone subject to drug testing.
Most patients who pursue BPC-157 have a soft-tissue issue (tendon, ligament, recurrent strain) or persistent gut symptoms that haven’t fully resolved with the usual approaches. They have already worked on the basics: rehab, sleep, training load, anti-inflammatory diet for gut symptoms.
We’re cautious in patients with active or recent cancer (angiogenic effects are a theoretical concern), in pregnancy, and in any tested athlete. We talk through the evidence honestly before deciding to start.
Tissue work often pairs with skin and aesthetic work, especially around recovery from procedures. This protocol is often used to supplement other services like SkinPen microneedling, RF microneedling, and our laser series.
BPC-157 is not an FDA-approved drug. The peptides used in this protocol are sourced from specialty peptide distributors that perform Certificate of Analysis (COA) testing on every lot to confirm identity, purity, and concentration, and that operate under the regulatory and quality standards applicable to their industry. They have not been evaluated by the FDA for the diagnosis, treatment, cure, or prevention of any disease, and we treat their use as investigational and as part of an individualized wellness plan. The information on this page reflects published research, clinical experience, and what patients have reported. It is not a medical claim or a guarantee of any outcome.
If you have a soft-tissue or gut issue that hasn’t fully resolved and you want an honest conversation about whether BPC-157 fits, a consultation is the right next step.
Schedule a Consultation
Expert provider-led care.
BPC-157 is a synthetic peptide that has been studied for its interaction with biological signaling pathways related to tissue integrity and recovery processes. In a wellness setting, it is discussed as a supportive peptide, not as a medication or treatment for disease.
No. BPC-157 is not FDA-approved for the diagnosis, treatment, cure, or prevention of any disease. When discussed in a medical wellness context, it is reviewed carefully so patients understand its status, limitations, and uncertainties.
BPC-157 may be discussed with individuals interested in general recovery support, physical resilience, or wellness optimization during periods of increased physical demand. It is not positioned as a treatment for injuries, pain, inflammation, or medical conditions.
No. BPC-157 is not used to treat injuries, illnesses, or medical conditions. It is not a substitute for medical care, rehabilitation, or evidence-based treatment plans. Any discussion of peptide therapy remains within a wellness and educational framework.
At Olympia Aesthetics & Wellness, peptide therapy is approached conservatively and within a physician-guided evaluation. If BPC-157 is discussed, factors such as individual goals, health history, and overall wellness strategy are reviewed before any decisions are made.
No. Peptide therapy is not appropriate for all individuals. Suitability varies based on medical history, current health status, and personal goals. A consultation is required to determine whether discussion of peptide therapy is appropriate.
No. Outcomes cannot be predicted or guaranteed. Responses vary between individuals, and peptide therapy should not be viewed as a guaranteed solution or outcome-based intervention.
When peptide therapy is considered, it is typically approached as a time-limited and reassessed wellness intervention, rather than an indefinite or automatic program. Ongoing evaluation is part of responsible use.
The best way to determine whether peptide therapy should even be discussed is through a medical consultation. This visit focuses on education, appropriateness, and safety — not commitment or pressure.
Contact information is for the sole use of
Olympia Aesthetics & Wellness and will not be redistributed.
Olympia Aesthetics & Wellness
33295 US Hwy 19 N #109
Palm Harbor, FL 34684
(727) 274-1972
Get directions
10 am – 6 pm Monday
10 am – 6 pm Tuesday
10 am – 6 pm Wednesday
10 am – 6 pm Thursday
10 am – 6 pm Friday
10 am – 2 pm Saturday
10 am – 2 pm Sunday
Accessibility: Olympia Aesthetics & Wellness is committed to ensuring our website is accessible to all users. If you experience any difficulty, please contact us at (727) 274 – 1972 or olympia@olympiaaesthetics.com. Click for more details